JBI-589

• CAT Number: I041086
• CAS Number: 2308504-22-3
• Molecular Formula: C29H28FN5O
• Molecular Weight: 481.56
• Purity: ≥95%
• Synonyms: [(3R)-3-aminopiperidin-1-yl]-[2-[1-[(4-fluorophenyl)methyl]indol-2-yl]-3-methylimidazo[1,2-a]pyridin-7-yl]methanone
• InChI: InChI=1S/C29H28FN5O/c1-19-28(32-27-16-22(12-14-34(19)27)29(36)33-13-4-6-24(31)18-33)26-15-21-5-2-3-7-25(21)35(26)17-20-8-10-23(30)11-9-20/h2-3,5,7-12,14-16,24H,4,6,13,17-18,31H2,1H3/t24-/m1/s1
• InChIKey: DUVCPNSLXBKGOK-XMMPIXPASA-N
• SMILES: CC1=C(N=C2N1C=CC(=C2)C(=O)N3CCC[C@H](C3)N)C4=CC5=CC=CC=C5N4CC6=CC=C(C=C6)F

JBI-589（Cat No.:I041086）is a small molecule inhibitor designed to target and inhibit a specific protein involved in cancer cell proliferation and survival. By interfering with key signaling pathways, JBI-589 disrupts tumor growth and induces apoptosis in cancer cells. It has shown promising activity in preclinical studies, particularly in targeting cancers resistant to conventional therapies. JBI-589 is being explored as a potential therapeutic option for various solid tumors and hematological malignancies. Its selective action offers the possibility of reducing side effects, making it a promising candidate for targeted cancer treatment.